Skip to main content
NCBI home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1983 Jun;37(2):137–140. doi: 10.1136/jech.37.2.137

Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales.

J W Yarnell, A M Fehily, J Milbank, A J Kubicki, R Eastham, T M Hayes
PMCID: PMC1052277  PMID: 6886584

Abstract

Dietary, social, and constitutional determinants of plasma concentrations of some major risk factors for ischaemic heart disease were investigated in a cross sectional study among 711 men from the general population aged 30-69. For high density lipoprotein cholesterol (HDL-C) six variables were significantly associated with plasma concentrations, and these variables explained 12.6% of the variance. For low density lipoprotein cholesterol (LDL-C), total cholesterol (T-C), and triglyceride 8.4%, 7.5%, and 18.5% of the variance was explained by significantly associated variables. Fibrinogen concentrations determined chemically were significantly associated with age, smoking habit, body mass index, alcohol consumption, and intake of cereal fibre (24.2% variance). These data provide some encouragement for the possibility of dietary intervention to influence plasma concentrations of major risk factors for ischaemic heart disease in men.

Full text

PDF
137

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker I. A., Eastham R., Elwood P. C., Etherington M., O'Brien J. R., Sweetnam P. M. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J. 1982 May;47(5):490–494. doi: 10.1136/hrt.47.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973 May;19(5):476–482. [PubMed] [Google Scholar]
  3. CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. doi: 10.1159/000205234. [DOI] [PubMed] [Google Scholar]
  4. Fehily A. M., Milbank J. E., Yarnell J. W., Hayes T. M., Kubiki A. J., Eastham R. D. Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure. Am J Clin Nutr. 1982 Nov;36(5):890–896. doi: 10.1093/ajcn/36.5.890. [DOI] [PubMed] [Google Scholar]
  5. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  6. Goldbourt U., Medalie J. H. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol. 1979 Mar;109(3):296–308. doi: 10.1093/oxfordjournals.aje.a112683. [DOI] [PubMed] [Google Scholar]
  7. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  8. Harkness J. The viscosity of human blood plasma; its measurement in health and disease. Biorheology. 1971 Dec;8(3):171–193. doi: 10.3233/bir-1971-83-408. [DOI] [PubMed] [Google Scholar]
  9. Meade T. W., Chakrabarti R., Haines A. P., North W. R., Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979 Jan 20;1(6157):153–156. doi: 10.1136/bmj.1.6157.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  11. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  12. Nemerson Y., Clyne L. P. An assay for coagulation factor VII using factor VII-depleted bovine plasma. J Lab Clin Med. 1974 Feb;83(2):301–303. [PubMed] [Google Scholar]
  13. PILGERAM L. O. Relation of plasma fibrinogen concentration changes to human arteriosclerosis. J Appl Physiol. 1961 Jul;16:660–664. doi: 10.1152/jappl.1961.16.4.660. [DOI] [PubMed] [Google Scholar]
  14. Steele B. W., Koehler D. F., Kuba K., Azar M. M. An enzymatic approach to lipoprotein quantification. Am J Clin Pathol. 1980 Jan;73(1):75–78. doi: 10.1093/ajcp/73.1.75. [DOI] [PubMed] [Google Scholar]
  15. Thorp J. M., Horsfall G. B., Stone M. C. A new red-sensitive micronephelometer. Med Biol Eng. 1967 Jan;5(1):51–56. doi: 10.1007/BF02478842. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES